Convergene

Developing dual inhibitors for rare diseases and cancer therapies

placeGaithersburg, Maryland, United States calendar_todayFounded 2011 groups5 employees language convergenepharma.com

Innovation

4 patent families (3 granted) — focus: Chemistry & metallurgy; filing pace steady. Cited 706 times.

YearFilings
20151
20162
20173
20183
20193
20203
20213
20222
20231
20242
20252
20261

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon